Biochemical and Biophysical Research Communications, Vol.453, No.1, 124-130, 2014
EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-beta
Histone methylation is involved in various biological and pathological processes including cancer development. In this study, we found that EED, a component of Polycomb repressive complex-2 (PRC2) that catalyzes methylation of lysine 27 of histone H3 (H3K27), was involved in epithelial-mesenchymal transition (EMT) of cancer cells induced by Transforming Growth Factor-beta (TGF-beta). The expression of EED was increased during TGF-beta-induced EMT and knockdown of EED inhibited TGF-beta-induced morphological conversion of the cells associated with EMT. EED knockdown antagonized TGF-beta-dependent expression changes of EMT-related genes such as CDH1, ZEB1, ZEB2 and microRNA-200 (miR-200) family. Chromatin immunoprecipitation assays showed that EED was implicated in TGF-beta-induced transcriptional repression of CDH1 and miR-200 family genes through the regulation of histone H3 methylation and EZH2 occupancies on their regulatory regions. Our study demonstrated a novel role of EED, which regulates PRC2 activity and histone methylation during TGF-beta-induced EMT of cancer cells. (C) 2014 Elsevier Inc. All rights reserved.
Keywords:Epithelial-mesenchymal transition;Histone methylation;Transcriptional regulation;microRNA;Cancer progression